ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1659

Shared Lung and Joint T Cell Repertoire in Early Rheumatoid Arthritis Driven by Cigarette Smoking

Koen Venken1, Matthias Jarlborg1, Frederik Stevenaert2, Thomas Malfait3, Carolien Vlieghe1, Yann Abraham2, Teddy Manuello1, Tine Decruy1, Stijn Van Hee1, Hans Wils2, Pieter Peeters2, Philippe Carron4, Filip Van den Bosch3, Viggo Van Tendeloo2, Bart Lambrecht1, Ruth Wittoek5, Peggy Jacques6 and Dirk Elewaut7, 1VIB Center for Inflammation Research - Ghent University, Ghent, Belgium, 2Janssen Research and Development, Beerse, Belgium, 3Ghent University Hospital, Ghent, Belgium, 4UZ Gent, Gent, Belgium, 5Dept. of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, 6University Hospital of GHent, Gent, Belgium, 7Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, rheumatoid arthritis, Smoking, T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: RA – Etiology and Pathogenesis I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Cigarette smoking has been associated with the production of anti-citrullinated protein antibodies (ACPA) and an increased risk of developing rheumatoid arthritis (RA) in individuals carrying shared epitope (SE) containing HLA-DR4 alleles. Yet, little is known on the regional and systemic T cell dynamics in response to smoking and a potential link to T cell infiltration in inflamed synovia remains to be explored. In this study, we therefore sought to study T cell features in lung and inflamed joints in human RA disease.

Methods: We set up a unique framework to monitor T cells in paired bronchoalveolar lavage (BAL) fluid, blood and inflamed synovium tissue samples collected in a one-day procedure from 17 new onset treatment naïve ACPA+ RA patients. T cell receptor (TCR) repertoire of index-sorted tissue residing T cells was determined by single-cell TCR sequencing coupled to deep immunophenotyping via Freeviz modelling of flow cytometry data.

Results: A significant enrichment of CD4+ and CD8+ T cells was seen in synovial samples from smoking versus non-smoking patients, along with an increase in expanded T cell clonotypes and TCR richness and alpha-diversity. T cell clonal expansions in synovium and lung (BAL) samples were particularly pronounced among SE+ smokers, suggesting a synergistic gene-smoke risk. Strikingly, identical TCR clonalities were present in matched lung and joint samples of RA smokers, the majority being also detectable in circulation. This was mirrored by an increased clustering of lung and synovium TCRs across patients, suggesting a shared specificity by conserved motifs. The lung-joint shared T cell clonotypes showed a restricted TCR gene usage and exhibited a particular CD57hi effector profile within the inflamed synovium. 

Conclusion: These data are compatible with a model whereby smoking instigates the induction of an early wave of pathogenic T cells in genetically susceptible individuals at mucosal sites which evolves into joint inflammation. Collectively, the data indicate a profound interplay between a strong MHC predisposition, smoking and induction of autoimmunity by shaping the TCR repertoire.


Disclosures: K. Venken: None; M. Jarlborg: None; F. Stevenaert: Janssen Research and Development – J&J, 3; T. Malfait: None; C. Vlieghe: None; Y. Abraham: Janssen Research and Development – J&J, 3, 11; T. Manuello: None; T. Decruy: None; S. Van Hee: None; H. Wils: Janssen Research and Development – J&J, 3; P. Peeters: Janssen Research and Development – J&J, 3; P. Carron: None; F. Van den Bosch: AbbVie/Abbott, 2, 6, Amgen, 6, Eli Lilly, 2, Fresenius Kabi, 6, Galapagos, 2, Janssen, 6, Novartis, 6, UCB, 6; V. Van Tendeloo: Janssen Research and Development – J&J, 3, 11; B. Lambrecht: None; R. Wittoek: None; P. Jacques: None; D. Elewaut: None.

To cite this abstract in AMA style:

Venken K, Jarlborg M, Stevenaert F, Malfait T, Vlieghe C, Abraham Y, Manuello T, Decruy T, Van Hee S, Wils H, Peeters P, Carron P, Van den Bosch F, Van Tendeloo V, Lambrecht B, Wittoek R, Jacques P, Elewaut D. Shared Lung and Joint T Cell Repertoire in Early Rheumatoid Arthritis Driven by Cigarette Smoking [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/shared-lung-and-joint-t-cell-repertoire-in-early-rheumatoid-arthritis-driven-by-cigarette-smoking/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/shared-lung-and-joint-t-cell-repertoire-in-early-rheumatoid-arthritis-driven-by-cigarette-smoking/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology